Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Up-and-Coming Automation Company Berkeley Lights Raises $95 Million

Emeryville, Calif.-based Berkeley Lights closed on a $95 million financing round, led by Nikon.

Read More »

Ionis and Roche agree on dry AMD treatment deal

Ionis Pharmaceuticals inked a deal worth more than $700 million with pharma giant Roche to develop an antisense drug for the treatment of complement-mediated diseases.

Read More »

J&J, Arrowhead reach gene-silencing drug deal

J&J agreed to develop and market Arrowhead Pharmaceuticals Inc.’s gene-silencing hepatitis B treatment and buy a minor stake in a deal that could be potentially worth more than $3.7 billion.

Read More »

Boston Pharma Doubles Pipeline with 2 Deals with Novartis and GSK

Boston Pharmaceuticals licenses a slew of compounds from GlaxoSmithKline and Novartis in two separate deals.

Read More »

Five-Member GO Therapeutics Inks Deal with Roche

GO Therapeutics, with headquarters in Cambridge, Mass., signed a licensing deal with Swiss-based Roche to develop antibodies for cancer.

Read More »

Janssen Terminates Collaboration with Aduro Biotech

Janssen Biotech informed Aduro Biotech that the Johnson & Johnson company was terminating a research and license deal related to Aduro’s Listeria treatment for cancers.

Read More »

Dragonfly and Merck Strike Deal for Solid Tumors

Waltham, Mass.-based Dragonfly Therapeutics struck a licensing agreement worth up to $695 million with Merck, which will license exclusive rights to Dragonfly’s TriNKET technology platform for a number of solid-tumor programs.

Read More »

Roche to acquire immuno-oncology company Tusk Therapeutics

Switzerland’s Roche is buying UK-based Tusk Therapeutics in a deal that could hit EUR 655 million.

Read More »

J&J Terminates Imetelstat Collaboration with Geron

Johnson & Johnson and Geron had teamed up to develop and commercialize imetelstat, a first-in-class telomerase inhibitor, for myelofibrosis and myelodysplastic syndromes.

Read More »

Brooks Automation Moves Further into Life Sciences with $450 Million Deal for Genewiz Group

Brooks Automation will increase the automation and cryogenics specialist’s toehold in the life sciences industry with a $450 million all-cash acquisition of genomic services group Genewiz.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom